Ranbaxy Faces False Marking Suit Over Exelderm
Promote Innovation LLC has accused Ranbaxy Laboratories Inc. of injuring the U.S. government and stifling industry innovation by marking a line of anti-fungus products with a patent that expired in 1996....To view the full article, register now.
Already a subscriber? Click here to view full article